Beta-Adrenergic Receptor Pharmacology and Heart Failure

A set of vocabulary flashcards detailing beta-1 adrenoceptor signaling pathways, antiarrhythmic actions, and therapeutic strategies for managing acute and chronic heart failure.

Beta-adrenergic receptor antagonists

Class 2 antiarrhythmic drugs, commonly known as beta blockers, that antagonize the $\beta_1$ adrenoceptor to compete with circulating adrenaline and noradrenaline, thereby reducing heart rate and force of contraction.

$\beta_1$ adrenoceptor

A G protein-coupled receptor highly expressed on cardiac cell plasma membranes that increases heart rate and force of contraction upon binding adrenaline or noradrenaline.

Positive chronotropy

An increase in heart rate.

Positive inotropy

An increase in the force of cardiac muscle contraction.

$$G\alpha_s$$

The G protein subunit that dissociates from the $G\alpha\beta\gamma$ heterotrimer upon $\beta_1$ adrenoceptor activation to stimulate adenylate cyclase and enhance ATP conversion to cAMP.

Protein kinase A

An enzyme activated by elevated cAMP levels that phosphorylates myosin and stimulates calcium release from intracellular stores to increase contractility force.

Chronic heart failure

A condition characterized by cardiac output being insufficient to meet the body's oxygenated blood demands, managed primarily by reducing cardiac pre-load and overall cardiac work.

Frank-Starling law

A physiological mechanism wherein reducing cardiac pre-load decreases the work done by the heart, and slowing heart rate lengthens diastolic filling time to maintain stroke volume.

Acute heart failure

A condition where cardiac output rapidly declines and must be quickly restored using $\beta_1$ agonists to prevent organ hypoperfusion and supply critical organs with oxygenated blood.

Cardiogenic shock

The most severe manifestation of acute heart failure, frequently caused by acute coronary syndromes, where prioritizing organ perfusion is the urgent objective.

Dobutamine

A somewhat selective, high-efficacy $\beta_1$ adrenoceptor agonist used to rapidly elevate heart rate and contractility in cardiogenic shock and severe acute heart failure.

Vaughn-Williams classification

A system used to categorize antiarrhythmic drugs, placing beta-adrenergic receptor antagonists into Class 2.